Insulin_Glulisine: profile and news

Apidra (insulin glulisine [rDNA origin] injection) Now Available ... Feb 28, 2006
BRIDGEWATER, NJ -- February 28, 2006 -- Sanofi-aventis US announced today that Apidra® (insulin glulisine [rDNA origin] injection), a new prandial or mealtime ... - DG News

Apidra(R) - a New Rapid-Acting Insulin Analog - Is Now Available ... Feb 28, 2006
28 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra(R) (insulin glulisine [rDNA origin] injection), a new prandial or mealtime insulin ... - PR Newswire (press release),

Apidra - a New Rapid-Acting Insulin Analog - Is Now Available in ... Feb 28, 2006
BRIDGEWATER, NJ, February 28, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra(R) (insulin glulisine [rDNA origin] injection), a ... - PharmaLive.com (press release),

Apidra(R) - a New Rapid-Acting Insulin Analog - Is Now Available ... Feb 28, 2006
28 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra® (insulin glulisine [rDNA origin] injection), a new prandial or mealtime insulin ... - Yahoo! News (press release)

Sanofi's Apidra hits the US market Mar 2, 2006
Sanofi says Apidra (insulin glulisine rDNA origin injection) is to be used in regimens that include a longer-acting insulin or basal insulin analog such as ... - Pharmaceutical Business Review

Data at EASD suggests better glycaemic control possible using ... Sep 15, 2005
2. Findings from a separate study using Apidra® (insulin glulisine), showed that people with type 2 diabetes receiving Apidra® as well as NPH insulin achieve ... - Läkemedelsindustriföreningen (pressmeddelande),